25 Oct 2025
Long-term follow-up of the PARTNER 3 Low-Risk randomized trial: Seven-year clinical and echocardiographic outcomes
Reported from TCT 2025
Mirvat Alasnag interviews Michael J. Mack on ........ he/she presented at TCT 2025 in San Francisco.
Authors
